Radiolabeled darapladib and analogs thereof and their use as imaging compounds
Номер патента: EP3687980A1
Опубликовано: 05-08-2020
Автор(ы): Emmanuelle JESTIN, Florian GUIBBAL, Olivier Meilhac, Sébastien BENARD
Принадлежит: Institut National de la Sante et de la Recherche Medicale INSERM, Universite de La Reunion, Universite de la Reunion Saint Denis
Опубликовано: 05-08-2020
Автор(ы): Emmanuelle JESTIN, Florian GUIBBAL, Olivier Meilhac, Sébastien BENARD
Принадлежит: Institut National de la Sante et de la Recherche Medicale INSERM, Universite de La Reunion, Universite de la Reunion Saint Denis
Реферат: The present inventors have developed new radiolabeled Darapladib and analogs thereof which can be used for the specific detection of vulnerable atherosclerotic plaques by targeting lipoprotein-associated phospholipase A2 (Lp-PLA2) which is a biomarker of choice concerning inflammation and atherosclerosis progression. Thus, the present invention relates to radiolabeled Darapladib and analogs thereof and their use as imaging compounds.
Dantrolene prodrugs and methods of their use
Номер патента: AU2023278113A1. Автор: Adrian HEPNER,Charles WESCOTT,Alyssa Larson. Владелец: Eagle Res Labs Ltd. Дата публикации: 2024-01-04.